Greenwich

Tropic Skincare Founder and CEO Regains Full Ownership of the Business

Retrieved on: 
Tuesday, April 4, 2023
Ambassador, Organic, Greenwich, Growth, HQ, Beauty, Pharmaceutical industry, Tropic Skincare

Founded in 2004 by acclaimed businesswoman, Susie Ma, Tropic has today announced the buyout of 50% shareholder, Lord Sugar.

Key Points: 
  • Founded in 2004 by acclaimed businesswoman, Susie Ma, Tropic has today announced the buyout of 50% shareholder, Lord Sugar.
  • "Twelve years after investing in Tropic Skincare, I have agreed with Susie Ma's decision to purchase back my shares and return sole ownership to her," says Lord Sugar.
  • "Susie is a shining example of what it is to be a business owner today.
  • "I will always be so grateful for the investment Lord Sugar made, and the potential he saw in Tropic Skincare with me at the helm.

Zions Bancorporation Receives 14 Greenwich Excellence Awards for 2022

Retrieved on: 
Thursday, March 2, 2023
Banking, Professional Services, Finance, Research, Zions Bancorporation, ZION, Greenwich

Zions Bancorporation (NASDAQ: ZION) is pleased to announce that it has received 14 Greenwich Excellence Awards for the year ended 2022, placing first in the nation for total awards issued in the middle market banking segment.

Key Points: 
  • Zions Bancorporation (NASDAQ: ZION) is pleased to announce that it has received 14 Greenwich Excellence Awards for the year ended 2022, placing first in the nation for total awards issued in the middle market banking segment.
  • Since the inception of the awards in 2009, Zions is one of only four U.S. banks to have averaged 15 or more Greenwich Excellence Awards annually.
  • These awards are based on 20,000 market research interviews with businesses nationwide, resulting in the evaluation of more than 500 banks, of which less than 35 were recognized with measurable distinctive quality.
  • “This recognition reflects the diligent work of our entire team of both front-line and behind-the-scenes professionals who deliver excellence every day.”
    Zions received Excellence awards in the following categories:

ANDREW (ANDY) MCCORMICK TO RETIRE FROM T. ROWE PRICE

Retrieved on: 
Thursday, February 9, 2023
GNMA, Chartered, Fitzsimons, City University, AllianceBernstein, FISC, Greenwich, NatWest Markets, City, University of London, Government National Mortgage Association, T. Rowe Price, Bank of America National Trust & Savings Ass'n v. 203 North LaSalle Street Partnership, CIO, National Crisis Management Committee, Bank, McCormick, Bayes Business School, Management, Security (finance)

BALTIMORE, Feb. 9, 2023 /PRNewswire/ -- T. Rowe Price, Inc. (NASDAQ-GS: TROW), announced today that Andrew (Andy) McCormick, head of the firm's Global Fixed Income division and one of the firm's chief investment officers (CIOs), plans to retire at the end of 2023. McCormick, who also serves as chair of T. Rowe Price's Fixed Income Steering Committee (FISC) and as a member of the firm's Management Committee, will be succeeded by Arif Husain, who is also one of the firm's CIOs and is currently head of International Fixed Income and a portfolio manager.

Key Points: 
  • BALTIMORE, Feb. 9, 2023 /PRNewswire/ -- T. Rowe Price, Inc. (NASDAQ-GS: TROW), announced today that Andrew (Andy) McCormick, head of the firm's Global Fixed Income division and one of the firm's chief investment officers (CIOs), plans to retire at the end of 2023.
  • McCormick joined T. Rowe Price in 2008 after beginning his investment career in 1983.
  • At that time, he will assume McCormick's position on T. Rowe Price's Management Committee and leadership of the FISC.
  • Following its typical robust succession planning process, T. Rowe Price has outlined a thoughtful transition for strategies currently led by Husain.

Kevin Campbell Joins Vita Inclinata as Executive Vice President of Finance

Retrieved on: 
Wednesday, September 28, 2022
Weather, Time, Campbell, Qualitative research, Corporation, Emergency medical services, Corporate finance, Treasury, Senior, Acquisition, Growth, Aviation, Patient, CEO, Greenwich, Air Methods, Research, Corporate development, Management, Finance

WASHINGTON, Sept. 28, 2022 /PRNewswire/ -- Vita Inclinata (Vita), developer and producer of precision aerospace and industrial stabilization devices, today announced the appointment of Kevin Campbell as Executive Vice President of Finance.

Key Points: 
  • WASHINGTON, Sept. 28, 2022 /PRNewswire/ -- Vita Inclinata (Vita), developer and producer of precision aerospace and industrial stabilization devices, today announced the appointment of Kevin Campbell as Executive Vice President of Finance.
  • Campbell is an experienced financial executive with a strong mix of technical, operational, strategic, and commercial finance skills and a history of building, leading, and motivating teams in high-growth, investment-oriented businesses.
  • In addition, he will be focused on scaling the finance and accounting functions to support this rapid growth.
  • Most recently, Campbell was Senior Vice President of Treasury and Corporate Development at Air Methods, which provides emergency medical services to over 100,000 patients annually in 48 states.

Infinix and Royal Observatory Greenwich Renew Corporate Partnership Ahead of ZERO ULTRA Launch

Retrieved on: 
Monday, September 26, 2022
Royal Observatory, Greenwich, Prime meridian (Greenwich), Time, Observatory, National Maritime Museum, AMAT, Museum, Smartphone, ZERO, Royal Museums Greenwich, Astronomy, Greenwich, Partnership, Imagination, Maritime museum, Technology, House, Collection, Queen, Research, Queen's House, Multimedia, Director of the Royal Greenwich Observatory, Education, ULTRA, Royal Observatory, Airline, Telescope, Mobile phone, Infinix Mobile

SHANGHAI, Sept. 26, 2022 /PRNewswire/ -- Global smartphone company, Infinix and the Royal Observatory Greenwich are thrilled to announce the renewal of their corporate partnership and co-operation with shared ambitions and spirit. The partnership aims to give the younger generation more opportunities to enjoy cutting-edge technologies and explore beyond the limits of their imagination. The move comes as Infinix ramps up for the launch of its most advanced flagship smartphone to date, ZERO ULTRA, which is set to hit the global market with an industry-first 180W Thunder Charge on October 5th.

Key Points: 
  • SHANGHAI, Sept. 26, 2022 /PRNewswire/ -- Global smartphone company, Infinix and the Royal Observatory Greenwich are thrilled to announce the renewal of their corporate partnership and co-operation with shared ambitions and spirit.
  • "Infinix is honored to continue its partnership with the Royal Greenwich Observatory, to keep empowering younger generations, especially in emerging markets and to encourage them to actively explore and discover more possibilities.
  • The Royal Observatory Greenwich is home of Greenwich Mean Time and the Prime Meridian and one of the most important historic scientific sites in the world.
  • The Royal Observatory Greenwich is part of Royal Museums Greenwich which also incorporates the National Maritime Museum, the Queen's House and Cutty Sark.

Infinix and Royal Observatory Greenwich Renew Corporate Partnership Ahead of ZERO ULTRA Launch

Retrieved on: 
Monday, September 26, 2022
Royal Observatory, Greenwich, Prime meridian (Greenwich), Time, Observatory, National Maritime Museum, AMAT, Museum, Smartphone, ZERO, Royal Museums Greenwich, Astronomy, Greenwich, Partnership, Imagination, Maritime museum, Technology, House, Collection, Queen, Research, Queen's House, Director of the Royal Greenwich Observatory, Education, ULTRA, Royal Observatory, Airline, Telescope, Mobile phone, Infinix Mobile

SHANGHAI, Sept. 26, 2022 /PRNewswire/ -- Global smartphone company, Infinix and the Royal Observatory Greenwich are thrilled to announce the renewal of their corporate partnership and co-operation with shared ambitions and spirit. The partnership aims to give the younger generation more opportunities to enjoy cutting-edge technologies and explore beyond the limits of their imagination. The move comes as Infinix ramps up for the launch of its most advanced flagship smartphone to date, ZERO ULTRA, which is set to hit the global market with an industry-first 180W Thunder Charge on October 5th.

Key Points: 
  • SHANGHAI, Sept. 26, 2022 /PRNewswire/ -- Global smartphone company, Infinix and the Royal Observatory Greenwich are thrilled to announce the renewal of their corporate partnership and co-operation with shared ambitions and spirit.
  • "Infinix is honored to continue its partnership with the Royal Greenwich Observatory, to keep empowering younger generations, especially in emerging markets and to encourage them to actively explore and discover more possibilities.
  • The Royal Observatory Greenwich is home of Greenwich Mean Time and the Prime Meridian and one of the most important historic scientific sites in the world.
  • The Royal Observatory Greenwich is part of Royal Museums Greenwich which also incorporates the National Maritime Museum, the Queen's House and Cutty Sark.

Searchlight Minerals Clarkdale Slag Project Update

Retrieved on: 
Friday, September 23, 2022
Observation, Greenwich, Glass, Queen's University, Temperature, CO, Zinc oxide, Colorado School of Mines, Pressure, Gold, Barrick, COC, Method, Dor, Zinc, Iron, Annual report, Clarkdale, Copper, Newmont Corporation, Arrakis, Naval Surface Warfare Center, Technology

The foremost technical issue delaying moving this project to production has been how to accurately analyze the raw slag and how to recover the gold on a consistent basis.

Key Points: 
  • The foremost technical issue delaying moving this project to production has been how to accurately analyze the raw slag and how to recover the gold on a consistent basis.
  • While the raw slag remains difficult to accurately analyze via fire assay due to the refractory nature of the slag, all of the processes tested yield gold dor beads on the process products allowing back calculated recovered gold grades.
  • Four processes have been evaluated in detail at bench and small pilot scale with the following results.
  • Pressure oxidation via autoclave Oxidizes the slag under elevated pressure and temperature so that it may be subsequently recovered from solution by leaching High capital and operating cost, moderate gold recovery.

Matinas BioPharma Announces Chairman Succession Plan

Retrieved on: 
Wednesday, September 21, 2022
Transfer, National, Risk, Sanofi, LNC, Icahn School of Medicine at Mount Sinai, Director, NYSE, Hoffmann-La Roche, MD, Organic acid, RNA transfection, Sale, Emory University, Audit committee, Pakistan Institute of Public Finance Accountants, Company, Consultant, Private Securities Litigation Reform Act, Nomination, Partnership, Industry, Forbes, Forward-looking statement, Technology, MBA, BS, Vaccine, Psychology, Shenzhen International BT Leadership Summit, Solution, Amikacin, Greenwich, NYU, BioNTech, Fourth Estate Public Benefit Corp. v. Wall-Street.com, Board, Merrill (company), Gilead Sciences, Research, DNA, GLOBE, SEC, Form 10-K, Management, Fine chemical, Herb, Matina Brothers, Genentech, Biology

Mr. Conrad, the founding Chairman of Matinas will remain on the Board as an independent director of the Company.

Key Points: 
  • Mr. Conrad, the founding Chairman of Matinas will remain on the Board as an independent director of the Company.
  • This change is representative of the progress we have made as a Company, commented Herbert J. Conrad, Chairman of Matinas .
  • I am honored to be appointed as the next Chairman of the Board at Matinas, stated Eric J. Ende .
  • Matinas BioPharma is a biopharmaceutical company focused on improving the intracellular delivery of nucleic acids and small molecules with its lipid nanocrystal (LNC) platform technology.

Greenwich LifeSciences Provides Updates on Upcoming Phase III Clinical Trial, Patent Filings, & AACR Meeting

Retrieved on: 
Thursday, March 3, 2022
Science, Other Science, Biotechnology, Research, Pharmaceutical, General Health, Health, Clinical Trials, Breast, Trastuzumab, Recurrence, Patient, Immunotherapy, Research, Phase, Greenwich, Woman, Population, Forward-looking statement, Strathcona County, Twitter, Breast cancer, MD Anderson Cancer Center, HLA, AACR, HER2/neu, Company, DTH, SEC, Cancer, Patent, Medicine, 2021 Essex County Council election, Nasdaq, Survivor, Prospectus, Pharmaceutical industry, GP2, the AACR Annual Meeting 2022, FLAMINGO-01 and GLSI-100, Breast Cancer and HER2/neu Positivity, Greenwich LifeSciences, Inc., GP2 Immunotherapy Immune Response, THE AACR ANNUAL MEETING 2022, FLAMINGO-01 AND GLSI-100, BREAST CANCER AND HER2/NEU POSITIVITY, GREENWICH LIFESCIENCES, INC., GP2 IMMUNOTHERAPY IMMUNE RESPONSE

Three abstracts/posters were accepted for presentation at the upcoming AACR Annual Meeting 2022.

Key Points: 
  • Three abstracts/posters were accepted for presentation at the upcoming AACR Annual Meeting 2022.
  • If these patent claims are issued, they have the potential to extend the patent life of GP2 beyond 2040.
  • The Phase III clinical trial will be called FLAMINGO-01 and the combination of GP2 + GM-CSF will be called GLSI-100.
  • Greenwich LifeSciences is planning to commence a Phase III clinical trial using a similar treatment regime as the Phase IIb clinical trial.

Greenwich LifeSciences to Present at 2022 BIO CEO & Investor Conference

Retrieved on: 
Thursday, February 3, 2022
Oncology, Health, Surgery, Clinical Trials, Pharmaceutical, Biotechnology, CEO, Forward-looking statement, Patient, MD Anderson Cancer Center, Cancer, SEC, Twitter, Immunotherapy, Woman, GM-CSF, Survivor, Population, Prospectus, Recurrence, Company, Breast, DTH, HER2/neu, Phase, Trastuzumab, Investment, BIO, HLA, Breast cancer, Conference, Greenwich, Nasdaq, Pharmaceutical industry, GP2, FLAMINGO-01 and GLSI-100, Breast Cancer and HER2/neu Positivity, Greenwich LifeSciences, Inc., GP2 Immunotherapy Immune Response, FLAMINGO-01 AND GLSI-100, BREAST CANCER AND HER2/NEU POSITIVITY, GREENWICH LIFESCIENCES, INC., GP2 IMMUNOTHERAPY IMMUNE RESPONSE

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the Company), a clinical-stage biopharmaceutical company focused on the development of GLSI-100, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery, today announced that Snehal Patel, CEO of Greenwich LifeSciences, will present in-person at 2:30 pm ET on February 14, 2022 at the 2022 BIO CEO & Investor Conference and will be available to participate in one-on-one meetings with qualified members of the investor community who are registered to attend the conference.

Key Points: 
  • Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the Company), a clinical-stage biopharmaceutical company focused on the development of GLSI-100, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery, today announced that Snehal Patel, CEO of Greenwich LifeSciences, will present in-person at 2:30 pm ET on February 14, 2022 at the 2022 BIO CEO & Investor Conference and will be available to participate in one-on-one meetings with qualified members of the investor community who are registered to attend the conference.
  • The 2022 BIO CEO & Investor Conference will be held from February 14-17, 2022.
  • For more than 20 years, the BIO CEO & Investor Conference has fueled biotech industry networking with premier investor and banking communities, focused on established and emerging publicly traded and select private biotech companies.
  • For more information on Greenwich LifeSciences, please visit the Companys website at www.greenwichlifesciences.com and follow the Company's Twitter at https://twitter.com/GreenwichLS .